TriMod Therapeutics is founded on ground-breaking cancer immunotherapy technology originating from the laboratory of Prof Kingston Mills at Trinity College Dublin.
TriMod faces significant expenses in travelling to the USA on a regular basis. The webcast that DV4 produced has reduced costs by generating more leads and qualifying prospects enabling TriMod to reduce travel expenditure and downtime.
The DV4 team were excellent to work with. The webcast they produced has been a great tool to introduce TriMod to potential collaborators and investors. The feedback has been very positive and clearly a good investment on our part.